Key facts
- This page summarizes Jane Ph D. Hsiao's Form 4 filing for OPKO HEALTH, INC. (OPK).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Jul 2024, 19:18.
Jane Ph D. Hsiao - 24 Jul 2024 Form 4 Insider Report for OPKO HEALTH, INC. (OPK)
- Reporting relationship
- Vice Chairman & CTO, Director
- Issuer ticker
- OPK
- Reported as of
- 24 Jul 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 Jul 2024, 19:18:18 UTC
- Prior SEC filing
- 17 Jan 2024
- Next SEC filing
- 29 May 2025
- Source filing
- View source filing
- Reporting owner signature
- Steven D. Rubin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jane Ph D. Hsiao filed Form 4 for OPKO HEALTH, INC. (OPK) on 26 Jul 2024.
Change
- Previous filing in this sequence was filed on 17 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OPK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +500,000
- Change %
- +1.8%
- Price
- $0.000000
- Shares after
- 28,499,880
- Date
- 24 Jul 2024
- Ownership
- Direct
- Footnotes
- F1
OPK
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,127,404
- Date
- 24 Jul 2024
- Ownership
- See Footnote
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of OPKO common stock upon the vesting of the award. The restricted stock units vest 50% on the second anniversary of the grant date, then 25% on each of the following two years.
Footnote F2
The securities are owned directly by Hsu Gamma Investment, L.P. Dr. Hsiao is the general partner of Hsu Gamma Investment, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.